163 related articles for article (PubMed ID: 38504180)
1. Prognostic marker CD27 and its micro-environmental in multiple myeloma.
Wang X; Luo K; Xu Q; Chi L; Guo Y; Jia C; Quan L
BMC Cancer; 2024 Mar; 24(1):352. PubMed ID: 38504180
[TBL] [Abstract][Full Text] [Related]
2. CD70 expression correlates with a worse prognosis in malignant pleural mesothelioma patients via immune evasion and enhanced invasiveness.
Inaguma S; Lasota J; Czapiewski P; Langfort R; Rys J; Szpor J; Waloszczyk P; Okoń K; Biernat W; Schrump DS; Hassan R; Kasai K; Miettinen M; Ikeda H
J Pathol; 2020 Feb; 250(2):205-216. PubMed ID: 31639216
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of prognosis and immune function of CD70-CD27 signaling axis in pan-cancer.
Kong F; Ye Q; Xiong Y
Funct Integr Genomics; 2023 Jan; 23(1):48. PubMed ID: 36700974
[TBL] [Abstract][Full Text] [Related]
4. CD70/CD27 signaling promotes blast stemness and is a viable therapeutic target in acute myeloid leukemia.
Riether C; Schürch CM; Bührer ED; Hinterbrandner M; Huguenin AL; Hoepner S; Zlobec I; Pabst T; Radpour R; Ochsenbein AF
J Exp Med; 2017 Feb; 214(2):359-380. PubMed ID: 28031480
[TBL] [Abstract][Full Text] [Related]
5. A possible role for the loss of CD27-CD70 interaction in myelomagenesis.
Katayama Y; Sakai A; Oue N; Asaoku H; Otsuki T; Shiomomura T; Masuda R; Hino N; Takimoto Y; Imanaka F; Yasui W; Kimura A
Br J Haematol; 2003 Jan; 120(2):223-34. PubMed ID: 12542479
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow microenvironments that contribute to patient outcomes in newly diagnosed multiple myeloma: A cohort study of patients in the Total Therapy clinical trials.
Danziger SA; McConnell M; Gockley J; Young MH; Rosenthal A; Schmitz F; Reiss DJ; Farmer P; Alapat DV; Singh A; Ashby C; Bauer M; Ren Y; Smith K; Couto SS; van Rhee F; Davies F; Zangari M; Petty N; Orlowski RZ; Dhodapkar MV; Copeland WB; Fox B; Hoering A; Fitch A; Newhall K; Barlogie B; Trotter MWB; Hershberg RM; Walker BA; Dervan AP; Ratushny AV; Morgan GJ
PLoS Med; 2020 Nov; 17(11):e1003323. PubMed ID: 33147277
[TBL] [Abstract][Full Text] [Related]
7. The CD70-CD27 axis in oncology: the new kids on the block.
Flieswasser T; Van den Eynde A; Van Audenaerde J; De Waele J; Lardon F; Riether C; de Haard H; Smits E; Pauwels P; Jacobs J
J Exp Clin Cancer Res; 2022 Jan; 41(1):12. PubMed ID: 34991665
[TBL] [Abstract][Full Text] [Related]
8. Expression of CD27-CD70 on early B cell progenitors in the bone marrow: implication for diagnosis and therapy of childhood ALL.
Nilsson A; de Milito A; Mowafi F; Winberg G; Björk O; Wolpert EZ; Chiodi F
Exp Hematol; 2005 Dec; 33(12):1500-7. PubMed ID: 16338493
[TBL] [Abstract][Full Text] [Related]
9. CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment.
Seyfrid M; Maich WT; Shaikh VM; Tatari N; Upreti D; Piyasena D; Subapanditha M; Savage N; McKenna D; Mikolajewicz N; Han H; Chokshi C; Kuhlmann L; Khoo A; Salim SK; Archibong-Bassey B; Gwynne W; Brown K; Murtaza N; Bakhshinyan D; Vora P; Venugopal C; Moffat J; Kislinger T; Singh S
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35017149
[TBL] [Abstract][Full Text] [Related]
10. Plasma CD27, a Surrogate of the Intratumoral CD27-CD70 Interaction, Correlates with Immunotherapy Resistance in Renal Cell Carcinoma.
Benhamouda N; Sam I; Epaillard N; Gey A; Phan L; Pham HP; Gruel N; Saldmann A; Pineau J; Hasan M; Quiniou V; Nevoret C; Verkarre V; Libri V; Mella S; Granier C; Broudin C; Ravel P; De Guillebon E; Mauge L; Helley D; Jabla B; Chaput N; Albiges L; Katsahian S; Adam J; Mejean A; Adotevi O; Vano YA; Oudard S; Tartour E
Clin Cancer Res; 2022 Nov; 28(22):4983-4994. PubMed ID: 36067339
[TBL] [Abstract][Full Text] [Related]
11. PLCE1 is a poor prognostic marker and may promote immune escape from osteosarcoma by the CD70-CD27 signaling pathway.
Huang L; Liao C; Wu H; Huang P
Bosn J Basic Med Sci; 2022 Oct; 22(6):992-1004. PubMed ID: 35765945
[TBL] [Abstract][Full Text] [Related]
12. Osteoclast precursors in murine bone marrow express CD27 and are impeded in osteoclast development by CD70 on activated immune cells.
Xiao Y; Song JY; de Vries TJ; Fatmawati C; Parreira DB; Langenbach GE; Babala N; Nolte MA; Everts V; Borst J
Proc Natl Acad Sci U S A; 2013 Jul; 110(30):12385-90. PubMed ID: 23832783
[TBL] [Abstract][Full Text] [Related]
13. CD27 antigen negative expression indicates poor prognosis in newly diagnosed multiple myeloma.
Chu B; Bao L; Wang Y; Lu M; Shi L; Gao S; Fang L; Xiang Q; Liu X
Clin Immunol; 2020 Apr; 213():108363. PubMed ID: 32120013
[TBL] [Abstract][Full Text] [Related]
14. CD70 reverse signaling enhances NK cell function and immunosurveillance in CD27-expressing B-cell malignancies.
Al Sayed MF; Ruckstuhl CA; Hilmenyuk T; Claus C; Bourquin JP; Bornhauser BC; Radpour R; Riether C; Ochsenbein AF
Blood; 2017 Jul; 130(3):297-309. PubMed ID: 28495792
[TBL] [Abstract][Full Text] [Related]
15. Epithelial and dendritic cells in the thymic medulla promote CD4+Foxp3+ regulatory T cell development via the CD27-CD70 pathway.
Coquet JM; Ribot JC; Bąbała N; Middendorp S; van der Horst G; Xiao Y; Neves JF; Fonseca-Pereira D; Jacobs H; Pennington DJ; Silva-Santos B; Borst J
J Exp Med; 2013 Apr; 210(4):715-28. PubMed ID: 23547099
[TBL] [Abstract][Full Text] [Related]
16. CD70 expression in tumor-associated fibroblasts predicts worse survival in colorectal cancer patients.
Inoue S; Ito H; Tsunoda T; Murakami H; Ebi M; Ogasawara N; Kasugai K; Kasai K; Ikeda H; Inaguma S
Virchows Arch; 2019 Oct; 475(4):425-434. PubMed ID: 30980190
[TBL] [Abstract][Full Text] [Related]
17. N-cadherin-mediated interaction with multiple myeloma cells inhibits osteoblast differentiation.
Groen RW; de Rooij MF; Kocemba KA; Reijmers RM; de Haan-Kramer A; Overdijk MB; Aalders L; Rozemuller H; Martens AC; Bergsagel PL; Kersten MJ; Pals ST; Spaargaren M
Haematologica; 2011 Nov; 96(11):1653-61. PubMed ID: 21828122
[TBL] [Abstract][Full Text] [Related]
18. [BAFF level in bone marrow and expression of BAFF receptor on B cells in multiple myeloma patients].
Zhou ZH; Zhang L; Pan QY; Huang BH; Zheng D; Liu JR; Li J; Luo SK
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Oct; 20(5):1131-4. PubMed ID: 23114133
[TBL] [Abstract][Full Text] [Related]
19. CD70 Activation Decreases Pulmonary Fibroblast Production of Extracellular Matrix Proteins.
Tran-Nguyen TK; Xue J; Feghali-Bostwick C; Sciurba FC; Kass DJ; Duncan SR
Am J Respir Cell Mol Biol; 2020 Aug; 63(2):255-265. PubMed ID: 32320626
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD27 and its ligand, CD70, on chronic lymphocytic leukemia B cells.
Ranheim EA; Cantwell MJ; Kipps TJ
Blood; 1995 Jun; 85(12):3556-65. PubMed ID: 7540066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]